Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.69 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.62 |
| ▸ | LTA4H | P09960 | 1/20 | 0.61 |
| ▸ | NPY1R | P25929 | 1/20 | 0.59 |
| ▸ | NPY2R | P49146 | 1/20 | 0.59 |
| ▸ | NPY4R | P50391 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.57 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14940816 | 1.00 | FOLH1 (0.69) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29532240 | 1.00 | FOLH1 (0.69) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| Hydrochloric Acid SCHEMBL30698091 | 0.99 | FOLH1 (0.67) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29531738 | 0.97 | FOLH1 (0.66) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL30683246 | 0.97 | FOLH1 (0.66) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29477112 | 0.97 | FOLH1 (0.66) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL29822390 | 0.96 | FOLH1 (0.68) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL3059716 | 0.94 | FOLH1 (0.62) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL2197916 | 0.94 | FOLH1 (0.62) | FOLH1OPRD1LTA4HNPY1RNPY2R | |
| SCHEMBL3059707 | 0.94 | FOLH1 (0.62) | FOLH1OPRD1LTA4HNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085094-A1 | STAPLED PEPTIDE AND USE THEREOF | JIANGSU DEYUAN PHARMACEUTICAL CO LTD (CN) | 2026-03-26 | — | — | US | claimed |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260001910-A1 | PEPTIDES AND USES THEREOF | PREVECEUTICAL MEDICAL INC (CA) | 2026-01-01 | — | — | US | claimed |
| US-20250188115-A1 | PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2025-06-12 | — | — | US | claimed |
| EP-4520766-A1 | OVARY-TARGETING POLYPEPTIDE, AND DERIVATIVE AND USE THEREOF | Shenzhen Institute of Advanced Technology Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | claimed |
| US-20250057911-A1 | OVARY-TARGETING POLYPEPTIDE, AND DERIVATIVE AND THE USE THEREOF | SHENZHEN INSTITUTES OF ADVANCEDTECHNOLOGY CHINESE ACADEMY OF SCIENCES (CN) | 2025-02-20 | — | — | US | claimed |
| WO-2024235082-A1 | USE OF SARDINE PEPTIDE COMPOSITION IN DRUG FOR TREATING ALLERGIC RHINITIS | 海口桥水联合科技有限责任公司 | 2024-11-21 | — | — | WO | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| EP-4433495-A1 | PEPTIDES AND USES THEREOF | Preveceutical Medical Inc. (CA) | 2024-09-25 | — | — | EP | claimed |
| CN-116350746-B | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117567562-A | Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide as well as preparation method and application thereof | 中国水产科学研究院黄海水产研究所 | 2024-02-20 | — | — | CN | claimed |
| CN-117050142-A | Ovarian targeting polypeptide, derivative and application thereof | 中国科学院深圳先进技术研究院 | 2023-11-14 | — | — | CN | claimed |
| WO-2023213141-A1 | OVARY-TARGETING POLYPEPTIDE, AND DERIVATIVE AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2023-11-09 | — | — | WO | claimed |
| CN-116804045-A | Polypeptide targeting HPV16E6 protein and preparation method and application thereof | 东南大学 | 2023-09-26 | — | — | CN | claimed |
| CN-116350746-A | Application of sardine peptide composition in medicines for treating allergic rhinitis | 海口桥水联合科技有限责任公司 | 2023-06-30 | — | — | CN | claimed |
| CN-114380902-B | Preparation method of HGH (176-191) | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-16 | — | — | CN | claimed |
| WO-2023089542-A1 | PEPTIDES AND USES THEREOF | PreveCeutical Medical Inc. (CA) | 2023-05-25 | — | — | WO | claimed |
| WO-2023088140-A1 | STAPLED PEPTIDE AND USE THEREOF | 南京明德新药研发有限公司 | 2023-05-25 | — | — | WO | claimed |
| US-20220168396-A1 | MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2022-06-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001910-A1 | PEPTIDES AND USES THEREOF | MMP3, PEPD, MMP9 | FOLH1 88/4885OPRD1 722/4885LTA4H 2386/4885 |
| US-20250188115-A1 | PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE | GLP1R, IAPP, GCG | FOLH1 97/4885OPRD1 4401/4885LTA4H 3465/4885 |
| US-20260085094-A1 | STAPLED PEPTIDE AND USE THEREOF | VIP, ARGLU1, NGLY1 | FOLH1 252/4885OPRD1 3819/4885LTA4H 2819/4885 |
| US-20220168396-A1 | MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF | GLP1R, GIPR, GCGR | FOLH1 1450/4885OPRD1 426/4885LTA4H 3963/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | FOLH1 274/4885OPRD1 933/4885LTA4H 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.